Marina Udier
Director/Board Member at CELYAD ONCOLOGY SA
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Michel Lussier | M | 67 | 17 years | |
Elisa Scarselli | F | - |
Nouscom Srl
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 17 years |
John McDonald | M | 63 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| 6 years |
Guido Magni | M | 70 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
Hilde Windels | F | 59 | 6 years | |
Joachim Rothe | M | - |
Nouscom Srl
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | - |
Genghis Lloyd-Harris | M | 67 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
Göran Albert Ando | M | 75 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| 4 years |
Cinzia Traboni | M | - |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 17 years |
Scott Rocklage | M | 69 |
Nouscom Srl
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | - |
Jean-Paul Prieels | M | 78 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland.
Nouscom Srl
| - |
Richard Davis | M | 51 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 4 years |
Dominic Piscitelli | M | 50 | 4 years | |
David Georges | M | - | 5 years | |
Eytan Breman | M | - | 9 years | |
Ami Patel Shah | F | - | 3 years | |
Sage Mandel | F | - | - | |
Richard Davis | M | 66 |
Nouscom Srl
| - |
Vincent Brichard | M | - |
Nouscom Srl
| - |
Jonathan M. James | M | - | - | |
J. Christopher LiPuma | M | 53 | 2 years | |
Serge Goblet | M | - | 16 years | |
An Phan | F | 49 | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Georges Rawadi | M | - | 5 years | |
Riccardo Cortese | M | 80 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 10 years |
Christian Homsy | M | 65 | 12 years | |
Patrick Jeanmart | M | 51 | 11 years | |
William Wijns | M | - | 9 years | |
Filippo Petti | M | 52 | 4 years | |
Sara Zelkovic | F | - | - | |
Peter de Waele | M | 67 | 7 years | |
Frederic Lehmann | M | 60 | 7 years | |
Hanspeter Spek | M | 72 | - | |
Margo Roberts | M | 69 | 2 years | |
Jean-Marc Heynderickx | M | 66 | 2 years | |
Debasish Francois Roychowdhury | M | 63 | - | |
Dieter Hauwaerts | M | - | 2 years | |
Chris de Jonghe | M | - | 4 years | |
Maria Koehler | M | 67 | - | |
Alfredo Nicosia | M | - |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | 12 years |
Stephen Rubino | M | 65 | 2 years | |
Anne Moore | M | - | - | |
Adrian Woolfson | M | 60 |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Nouscom AG engages in the development of genetic neoantigen vaccines and oncolytic viruses for prevention and treatment of cancer. Its product pipeline include Nous-209, Nous-PEV, and Nous-THV-001. The company was founded by Alfredo Nicosia, Antonella Folgori, Riccardo Cortese, Stefano Colloca, Cinzia Traboni, Elisa Scarselli, and Gabriella Campadelli in 2007 and is headquartered in Basel, Switzerland. | - |
Philippe Nobels | M | 58 | 7 years | |
Peggy Sotiropoulou | M | - | 4 years | |
Elena Spanjaard | M | - | 3 years | |
David Gilham | M | 59 | 6 years | |
Alexander M. Milstein | M | 65 | - | |
Steve Buckanavage | M | - | - | |
Richard Mountfield | M | - | - | |
Pierre Brynaert | M | - | - | |
Philippe Dechamps | M | 54 | 6 years | |
Warren Sherman | M | - | - | |
Chris Heymans | M | - | - | |
Jaak Minten | M | - | - | |
Charles Q. Morris | M | 59 | 2 years | |
Carri Duncan | M | - | - | |
Danny F. Wong | M | 61 | - | |
Gaëtane Metz | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
Belgium | 44 | 74.58% |
Switzerland | 13 | 22.03% |
Italy | 10 | 16.95% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Marina Udier
- Personal Network